title: Increased anthralin irritation response in vitiliginous skin.
abstract: The irritation response to anthralin was studied using the chamber-testing technique in 17 patients with vitiligo. Anthralin concentrations of 0.1%, 0.5%, 1%, and 5% in lanette wax were applied to both vitiliginous and adjacent pigmented skin for 24 h. The extent of the erythematous reaction was evaluated on the 2nd day after application. The visual assessment of the paired anthralin patches indicated that the erythema was more intense in pigmented skin than in vitiliginous skin in 15 out of 17 patients. Chromometer readings, however, clearly indicated that the erythematous response was stronger in the vitiliginous skin than in the pigmented skin, confirming the known fact that the human eye is not accurate in the quantitative assessment of complex colors. Immunophenotypification of cellular infiltrates, using the combination of different monoclonal antibodies and the peroxidase technique, showed that inflammatory cell infiltrates caused by the anthralin exposure contained increased numbers of granulocytes and monocytes in vitiliginous skin when compared with normal skin. The percentage of T-cell subsets, Langerhans cells, and mast cells in the same infiltrates of both types of skin were similar. Our results are discussed in accordance with the view that anthralin-induced radical species of the pigmented skin can be neutralized by the scavenging properties of melanin.
authors.affiliation: Department of Dermatology, University of Amsterdam, The Netherlands.
authors.forename: W
authors.initials: W
authors.lastname: Westerhof
authors.forename: Y
authors.initials: Y
authors.lastname: Buehre
authors.forename: S
authors.initials: S
authors.lastname: Pavel
authors.forename: J D
authors.initials: JD
authors.lastname: Bos
authors.forename: P K
authors.initials: PK
authors.lastname: Das
authors.forename: S R
authors.initials: SR
authors.lastname: Krieg
authors.forename: A H
authors.initials: AH
authors.lastname: Siddiqui
mesh_terms: D000328:Adult; D000875:Anthralin / Q000494:pharmacology*; D002452:Cell Count; D004890:Erythema / Q000473:pathology; D005260:Female; D006801:Humans; D007509:Irritants; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D012880:Skin Pigmentation; D014820:Vitiligo / Q000473:pathology*
chemical_list: D007509:Irritants; D000875:Anthralin